|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2013
12 months to Dec 31, 2013
|
FY2012
12 months to Dec 31, 2012
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Research and development | |||||
| General and administrative | |||||
| Advertising and marketing | |||||
| Legal and professional | |||||
| Impairment expense | |||||
| Total operating expenses | |||||
| Amortization of beneficial conversion | |||||
| Loss from operations | |||||
| Other expense: | |||||
| Interest expense | |||||
| Total other expense | |||||
| Net loss | |||||
| Common stock dividend | |||||
| Net loss available to common shareholders | |||||
| Basic | |||||
| Diluted | |||||
Loading...